Onpattro

heart model heart disease

Biotech

BridgeBio lifts the hood on phase 3 acoramidis data

BridgeBio is detailing mortality and hospitalization data from a phase 3 trial of acoramidis months after top-line results boosted the company.

Max Bayer Aug 28, 2023 11:21am

Wait empty bowl dog delay miss

AstraZeneca's wait for data in $3.5B Ionis partnership lengthens

Apr 29, 2022 11:59am

Nurse about to give an infusion

Alnylam touts data replication for next-generation Onpattro

Jan 21, 2022 11:40am